Connection

Igor Roninson to Humans

This is a "connection" page, showing publications Igor Roninson has written about Humans.
Connection Strength

0.682
  1. Systemic Toxicity Reported for CDK8/19 Inhibitors CCT251921 and MSC2530818 Is Not Due to Target Inhibition. Cells. 2019 11 09; 8(11).
    View in: PubMed
    Score: 0.026
  2. Identifying Cancers Impacted by CDK8/19. Cells. 2019 08 03; 8(8).
    View in: PubMed
    Score: 0.025
  3. CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases. Cancer Res. 2018 12 01; 78(23):6594-6606.
    View in: PubMed
    Score: 0.024
  4. CDK8/19 Mediator kinases potentiate induction of transcription by NF?B. Proc Natl Acad Sci U S A. 2017 09 19; 114(38):10208-10213.
    View in: PubMed
    Score: 0.022
  5. Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer. Curr Cancer Drug Targets. 2015; 15(8):739-49.
    View in: PubMed
    Score: 0.018
  6. Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities. Proc Natl Acad Sci U S A. 2012 Aug 21; 109(34):13799-804.
    View in: PubMed
    Score: 0.016
  7. A subunit of coatomer protein complex offers a novel tumor-specific target through a surprising mechanism. Autophagy. 2011 Dec; 7(12):1551-2.
    View in: PubMed
    Score: 0.015
  8. Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit ? 2 renders tumor cells dependent on its paralogous gene COPZ1. Proc Natl Acad Sci U S A. 2011 Jul 26; 108(30):12449-54.
    View in: PubMed
    Score: 0.014
  9. Function-based gene identification using enzymatically generated normalized shRNA library and massive parallel sequencing. Proc Natl Acad Sci U S A. 2010 Apr 20; 107(16):7377-82.
    View in: PubMed
    Score: 0.013
  10. Identification of single nucleotide polymorphisms in the p21 (CDKN1A) gene and correlations with longevity in the Italian population. Aging (Albany NY). 2009 May; 1(5):470-80.
    View in: PubMed
    Score: 0.012
  11. p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation. Oncogene. 2007 Oct 18; 26(48):6954-8.
    View in: PubMed
    Score: 0.011
  12. p21 (CDKN1A) is a negative regulator of p53 stability. Cell Cycle. 2007 Jun 15; 6(12):1468-71.
    View in: PubMed
    Score: 0.011
  13. Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells. Cancer Res. 2006 Dec 01; 66(23):11370-80.
    View in: PubMed
    Score: 0.011
  14. Cell cycle arrest drastically extends the duration of gene silencing after transient expression of short hairpin RNA. Cell Cycle. 2006 Oct; 5(20):2390-5.
    View in: PubMed
    Score: 0.010
  15. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells. Cancer Res. 2006 Sep 01; 66(17):8749-61.
    View in: PubMed
    Score: 0.010
  16. Seeking favors from nature. Cancer Biol Ther. 2005 Jul; 4(7):794-9.
    View in: PubMed
    Score: 0.010
  17. Induction of transcription by p21Waf1/Cip1/Sdi1: role of NFkappaB and effect of non-steroidal anti-inflammatory drugs. Cell Cycle. 2004 Jul; 3(7):931-40.
    View in: PubMed
    Score: 0.009
  18. Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity. Cancer Res. 2004 May 01; 64(9):2956-61.
    View in: PubMed
    Score: 0.009
  19. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene. 2004 Apr 12; 23(16):2919-33.
    View in: PubMed
    Score: 0.009
  20. Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements. Cancer Cell. 2003 Jul; 4(1):41-53.
    View in: PubMed
    Score: 0.008
  21. Tumor cell senescence in cancer treatment. Cancer Res. 2003 Jun 01; 63(11):2705-15.
    View in: PubMed
    Score: 0.008
  22. Genetic suppressor elements in the characterization and identification of tumor suppressor genes. Methods Mol Biol. 2003; 222:413-36.
    View in: PubMed
    Score: 0.008
  23. Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in?vitro and in?vivo. Proc Natl Acad Sci U S A. 2022 08 09; 119(32):e2201073119.
    View in: PubMed
    Score: 0.008
  24. Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett. 2002 May 08; 179(1):1-14.
    View in: PubMed
    Score: 0.008
  25. A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched Pharmacokinetics. J Med Chem. 2022 02 24; 65(4):3420-3433.
    View in: PubMed
    Score: 0.008
  26. Retinoid-induced growth arrest of breast carcinoma cells involves co-activation of multiple growth-inhibitory genes. Cancer Biol Ther. 2002 Jan-Feb; 1(1):24-7.
    View in: PubMed
    Score: 0.007
  27. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):389-94.
    View in: PubMed
    Score: 0.007
  28. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat. 2001 Oct; 4(5):303-13.
    View in: PubMed
    Score: 0.007
  29. Analysis of MDR1 P-glycoprotein conformational changes in permeabilized cells using differential immunoreactivity. Biochemistry. 2001 Apr 10; 40(14):4312-22.
    View in: PubMed
    Score: 0.007
  30. P-glycoprotein-mediated colchicine resistance in different cell lines correlates with the effects of colchicine on P-glycoprotein conformation. Biochemistry. 2001 Apr 10; 40(14):4323-31.
    View in: PubMed
    Score: 0.007
  31. Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein. Biochemistry. 2001 Apr 10; 40(14):4332-9.
    View in: PubMed
    Score: 0.007
  32. The Inhibition of CDK8/19 Mediator Kinases Prevents the Development of Resistance to EGFR-Targeting Drugs. Cells. 2021 01 12; 10(1).
    View in: PubMed
    Score: 0.007
  33. Pleiotropic resistance to DNA-interactive drugs is associated with increased expression of genes involved in DNA replication, repair, and stress response. Cancer Res. 2000 Sep 15; 60(18):5027-30.
    View in: PubMed
    Score: 0.007
  34. Effects of the multidrug transporter P-glycoprotein on cellular responses to ionizing radiation. Cancer Res. 2000 May 15; 60(10):2576-8.
    View in: PubMed
    Score: 0.007
  35. p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene. 2000 Apr 20; 19(17):2165-70.
    View in: PubMed
    Score: 0.007
  36. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci U S A. 2000 Apr 11; 97(8):4291-6.
    View in: PubMed
    Score: 0.007
  37. Characterizing CDK8/19 Inhibitors through a NF?B-Dependent Cell-Based Assay. Cells. 2019 10 06; 8(10).
    View in: PubMed
    Score: 0.006
  38. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene. 1999 Aug 26; 18(34):4808-18.
    View in: PubMed
    Score: 0.006
  39. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res. 1999 Aug 01; 59(15):3761-7.
    View in: PubMed
    Score: 0.006
  40. Structural insight into substrate and inhibitor discrimination by human P-glycoprotein. Science. 2019 02 15; 363(6428):753-756.
    View in: PubMed
    Score: 0.006
  41. A combination of genetic suppressor elements produces resistance to drugs inhibiting DNA replication. Somat Cell Mol Genet. 1999 Jan; 25(1):9-26.
    View in: PubMed
    Score: 0.006
  42. Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer. Oncogene. 2018 08; 37(35):4792-4808.
    View in: PubMed
    Score: 0.006
  43. Internal ribosomal entry site-containing retroviral vectors with green fluorescent protein and drug resistance markers. Hum Gene Ther. 1998 May 20; 9(8):1233-6.
    View in: PubMed
    Score: 0.006
  44. Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1. Proc Natl Acad Sci U S A. 2018 02 27; 115(9):E1973-E1982.
    View in: PubMed
    Score: 0.006
  45. Isolation of altered-function mutants and genetic suppressor elements of multidrug transporter P-glycoprotein by expression selection from retroviral libraries. Methods Enzymol. 1998; 292:225-48.
    View in: PubMed
    Score: 0.006
  46. P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity. Proc Natl Acad Sci U S A. 1997 Nov 25; 94(24):12908-13.
    View in: PubMed
    Score: 0.006
  47. Drug resistance conferred by MDR1 expression in spheroids formed by glioblastoma cell lines. Anticancer Res. 1997 Sep-Oct; 17(5A):3321-7.
    View in: PubMed
    Score: 0.006
  48. Applications of green fluorescent protein as a marker of retroviral vectors. Somat Cell Mol Genet. 1997 Sep; 23(5):325-40.
    View in: PubMed
    Score: 0.006
  49. Efficient recovery and regeneration of integrated retroviruses. Nucleic Acids Res. 1997 Jul 15; 25(14):2940-2.
    View in: PubMed
    Score: 0.005
  50. Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer. Oncotarget. 2017 Feb 21; 8(8):12558-12575.
    View in: PubMed
    Score: 0.005
  51. Isolation of genetic suppressor elements (GSEs) from random fragment cDNA libraries in retroviral vectors. Methods Mol Biol. 1997; 69:221-40.
    View in: PubMed
    Score: 0.005
  52. Inducible retroviral vectors regulated by lac repressor in mammalian cells. Gene. 1996 Dec 12; 183(1-2):137-42.
    View in: PubMed
    Score: 0.005
  53. Effects of infection rate and selection pressure on gene expression from an internal promoter of a double gene retroviral vector. Somat Cell Mol Genet. 1996 Jul; 22(4):291-309.
    View in: PubMed
    Score: 0.005
  54. Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing. Nat Cell Biol. 2016 07; 18(7):777-89.
    View in: PubMed
    Score: 0.005
  55. Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate. Int J Cancer. 1996 Mar 01; 65(5):613-9.
    View in: PubMed
    Score: 0.005
  56. P-glycoprotein confers methotrexate resistance in 3T6 cells with deficient carrier-mediated methotrexate uptake. Proc Natl Acad Sci U S A. 1996 Feb 06; 93(3):1238-42.
    View in: PubMed
    Score: 0.005
  57. Genetic suppressor elements: new tools for molecular oncology--thirteenth Cornelius P. Rhoads Memorial Award Lecture. Cancer Res. 1995 Sep 15; 55(18):4023-8.
    View in: PubMed
    Score: 0.005
  58. Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells. Oncotarget. 2015 May 30; 6(15):13088-104.
    View in: PubMed
    Score: 0.005
  59. Cloning mammalian genes by expression selection of genetic suppressor elements: association of kinesin with drug resistance and cell immortalization. Proc Natl Acad Sci U S A. 1994 Apr 26; 91(9):3744-8.
    View in: PubMed
    Score: 0.004
  60. Variable effects of sodium butyrate on the expression and function of the MDR1 (P-glycoprotein) gene in colon carcinoma cell lines. Int J Cancer. 1993 Sep 09; 55(2):297-302.
    View in: PubMed
    Score: 0.004
  61. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst. 1993 Apr 21; 85(8):632-9.
    View in: PubMed
    Score: 0.004
  62. Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA. Proc Natl Acad Sci U S A. 1993 Apr 15; 90(8):3231-5.
    View in: PubMed
    Score: 0.004
  63. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood. 1992 Dec 01; 80(11):2735-9.
    View in: PubMed
    Score: 0.004
  64. Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas. J Natl Cancer Inst. 1992 Oct 07; 84(19):1486-91.
    View in: PubMed
    Score: 0.004
  65. From amplification to function: the case of the MDR1 gene. Mutat Res. 1992 May; 276(3):151-61.
    View in: PubMed
    Score: 0.004
  66. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012 Apr; 8(4):445-544.
    View in: PubMed
    Score: 0.004
  67. Reactive oxygen species and mitochondrial sensitivity to oxidative stress determine induction of cancer cell death by p21. J Biol Chem. 2012 Mar 23; 287(13):9845-9854.
    View in: PubMed
    Score: 0.004
  68. The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo. Biochem Pharmacol. 1992 Jan 09; 43(1):95-102.
    View in: PubMed
    Score: 0.004
  69. TP53 codon 72 polymorphism affects accumulation of mtDNA damage in human cells. Aging (Albany NY). 2012 Jan; 4(1):28-39.
    View in: PubMed
    Score: 0.004
  70. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. Oncol Res. 1992; 4(7):281-90.
    View in: PubMed
    Score: 0.004
  71. Effects of conditional depletion of topoisomerase II on cell cycle progression in mammalian cells. Cell Cycle. 2011 Oct 15; 10(20):3505-14.
    View in: PubMed
    Score: 0.004
  72. Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection. Proc Natl Acad Sci U S A. 1991 Aug 15; 88(16):7386-90.
    View in: PubMed
    Score: 0.004
  73. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell. 1991 Jul 12; 66(1):85-94.
    View in: PubMed
    Score: 0.004
  74. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res. 1991 May 15; 51(10):2720-6.
    View in: PubMed
    Score: 0.004
  75. Molecular remodeling of potassium channels in fibroblasts from centenarians: a marker of longevity? Mech Ageing Dev. 2010 Nov-Dec; 131(11-12):674-81.
    View in: PubMed
    Score: 0.003
  76. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci U S A. 1990 09; 87(18):7160-4.
    View in: PubMed
    Score: 0.003
  77. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185----Val-185 substitution in P-glycoprotein. Proc Natl Acad Sci U S A. 1990 Sep; 87(18):7225-9.
    View in: PubMed
    Score: 0.003
  78. Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J Biol Chem. 1990 Jan 05; 265(1):506-14.
    View in: PubMed
    Score: 0.003
  79. Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro. Br J Cancer. 2009 Dec 01; 101(11):1900-8.
    View in: PubMed
    Score: 0.003
  80. Analysis of gene amplification in human tumor cells by in-gel DNA renaturation assay. Nihon Ketsueki Gakkai Zasshi. 1989 Dec; 52(8):1463-70.
    View in: PubMed
    Score: 0.003
  81. Structure and expression of the human MDR (P-glycoprotein) gene family. Mol Cell Biol. 1989 Sep; 9(9):3808-20.
    View in: PubMed
    Score: 0.003
  82. Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay. Cancer Res. 1989 Apr 01; 49(7):1693-7.
    View in: PubMed
    Score: 0.003
  83. mRNA phenotyping by enzymatic amplification of randomly primed cDNA. Nucleic Acids Res. 1988 Nov 11; 16(21):10366.
    View in: PubMed
    Score: 0.003
  84. Regulation of Sp1 by cell cycle related proteins. Cell Cycle. 2008 Sep 15; 7(18):2856-67.
    View in: PubMed
    Score: 0.003
  85. Analysis of gene amplification in human tumor cell lines. Proc Natl Acad Sci U S A. 1988 Sep; 85(18):6846-50.
    View in: PubMed
    Score: 0.003
  86. Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts. Aging Cell. 2008 Oct; 7(5):609-21.
    View in: PubMed
    Score: 0.003
  87. An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene. Cell. 1988 May 20; 53(4):519-29.
    View in: PubMed
    Score: 0.003
  88. Localization of the human multiple drug resistance gene, MDR1, to 7q21.1. Hum Genet. 1987 Oct; 77(2):142-4.
    View in: PubMed
    Score: 0.003
  89. Effect of target secondary structure on RNAi efficiency. RNA. 2007 Oct; 13(10):1631-40.
    View in: PubMed
    Score: 0.003
  90. Molecular mechanism of multidrug resistance in tumor cells. Clin Physiol Biochem. 1987; 5(3-4):140-51.
    View in: PubMed
    Score: 0.003
  91. The STAT3 oncogene as a predictive marker of drug resistance. Trends Mol Med. 2007 Jan; 13(1):4-11.
    View in: PubMed
    Score: 0.003
  92. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell. 1986 Nov 07; 47(3):381-9.
    View in: PubMed
    Score: 0.003
  93. Detection of amplified sequences in mammalian DNA by in-gel renaturation and SINE hybridization. Somat Cell Mol Genet. 1986 Nov; 12(6):611-23.
    View in: PubMed
    Score: 0.003
  94. Proteomic analysis of factors released from p21-overexpressing tumour cells. Proteomics. 2006 Jul; 6(13):3739-53.
    View in: PubMed
    Score: 0.003
  95. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci U S A. 1986 Jun; 83(12):4538-42.
    View in: PubMed
    Score: 0.003
  96. Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1. Cancer Res. 2005 Oct 01; 65(19):8927-35.
    View in: PubMed
    Score: 0.002
  97. Detection and mapping of homologous, repeated and amplified DNA sequences by DNA renaturation in agarose gels. Nucleic Acids Res. 1983 Aug 25; 11(16):5413-31.
    View in: PubMed
    Score: 0.002
  98. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein. Int J Oncol. 2000 Sep; 17(3):579-86.
    View in: PubMed
    Score: 0.002
  99. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells. Oncogene. 1999 Jan 14; 18(2):377-84.
    View in: PubMed
    Score: 0.002
  100. Isolation of efficient antivirals: genetic suppressor elements against HIV-1. Gene Ther. 1999 Jan; 6(1):130-7.
    View in: PubMed
    Score: 0.002
  101. Altered expression of ubiquitous kinesin heavy chain results in resistance to etoposide and hypersensitivity to colchicine: mapping of the domain associated with drug response. Cancer Res. 1998 Aug 01; 58(15):3423-8.
    View in: PubMed
    Score: 0.001
  102. Drug-stimulated nucleotide trapping in the human multidrug transporter MDR1. Cooperation of the nucleotide binding domains. J Biol Chem. 1998 Apr 24; 273(17):10132-8.
    View in: PubMed
    Score: 0.001
  103. Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine. Oncol Res. 1998; 10(4):185-92.
    View in: PubMed
    Score: 0.001
  104. Evaluation of newer prognostic markers for adult soft tissue sarcomas. J Clin Oncol. 1997 Oct; 15(10):3249-57.
    View in: PubMed
    Score: 0.001
  105. 60-Hz electric fields inhibit protein kinase C activity and multidrug resistance gene (MDR1) up-regulation. Radiat Res. 1997 Mar; 147(3):369-75.
    View in: PubMed
    Score: 0.001
  106. Identification of p53 genetic suppressor elements which confer resistance to cisplatin. Oncogene. 1997 Jan 16; 14(2):185-93.
    View in: PubMed
    Score: 0.001
  107. Inhibition of cytarabine-induced MDR1 (P-glycoprotein) gene activation in human tumor cells by fatty acid-polyethylene glycol-fatty acid diesters, novel inhibitors of P-glycoprotein function. Int J Cancer. 1996 Oct 09; 68(2):245-50.
    View in: PubMed
    Score: 0.001
  108. Adriamycin activates c-jun N-terminal kinase in human leukemia cells: a relevance to apoptosis. Cancer Lett. 1996 Oct 01; 107(1):73-81.
    View in: PubMed
    Score: 0.001
  109. Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes. Exp Hematol. 1996 Aug; 24(10):1258-64.
    View in: PubMed
    Score: 0.001
  110. Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein. J Biol Chem. 1996 Jan 26; 271(4):1877-83.
    View in: PubMed
    Score: 0.001
  111. Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit. Gene Ther. 1995 Jun; 2(4):279-84.
    View in: PubMed
    Score: 0.001
  112. Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators. Biochemistry. 1995 Jan 10; 34(1):32-9.
    View in: PubMed
    Score: 0.001
  113. Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P-glycoprotein. Int J Cancer. 1993 Sep 30; 55(3):478-84.
    View in: PubMed
    Score: 0.001
  114. MDR-1 expression in metastatic malignant melanoma. J Surg Res. 1993 Jun; 54(6):621-4.
    View in: PubMed
    Score: 0.001
  115. Chromosome 7 long arm deletion in myeloid disorders: a narrow breakpoint region in 7q22 defined by molecular mapping. Blood. 1989 Jan; 73(1):230-4.
    View in: PubMed
    Score: 0.001
  116. Autonomously replicating episomes contain mdr1 genes in a multidrug-resistant human cell line. Mol Cell Biol. 1989 Jan; 9(1):109-15.
    View in: PubMed
    Score: 0.001
  117. Detection of multidrug resistance markers, P-glycoprotein and mdr1 mRNA, in human leukemia cells. Jpn J Cancer Res. 1987 Dec; 78(12):1415-9.
    View in: PubMed
    Score: 0.001
  118. Decreased expression of the amplified mdr1 gene in revertants of multidrug-resistant human myelogenous leukemia K562 occurs without loss of amplified DNA. Mol Cell Biol. 1987 Dec; 7(12):4549-52.
    View in: PubMed
    Score: 0.001
  119. RFLPs associated with MDR2, a member of the human multidrug resistance gene family mapped to chromosome 7. Nucleic Acids Res. 1987 Aug 11; 15(15):6305.
    View in: PubMed
    Score: 0.001
  120. The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. J Biol Chem. 1987 Jan 15; 262(2):505-8.
    View in: PubMed
    Score: 0.001
  121. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun. 1986 Dec 30; 141(3):956-62.
    View in: PubMed
    Score: 0.001
  122. Multidrug resistance of DNA-mediated transformants is linked to transfer of the human mdr1 gene. Mol Cell Biol. 1986 Nov; 6(11):4039-45.
    View in: PubMed
    Score: 0.001
  123. Localization of multidrug resistance-associated DNA sequences to human chromosome 7. Somat Cell Mol Genet. 1986 Jul; 12(4):415-20.
    View in: PubMed
    Score: 0.001
  124. Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science. 1986 May 02; 232(4750):643-5.
    View in: PubMed
    Score: 0.001
  125. Acquisition and loss of amplified genes: dramatic effects of hormones, tumor promoters and cytotoxic drugs. Princess Takamatsu Symp. 1983; 14:235-54.
    View in: PubMed
    Score: 0.001
  126. Physical mapping of human adenovirus type 7 DNA using a simple and sensitive method of terminal labeling. Gene. 1982 May; 18(2):123-31.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.